AQST EBITDA
Aquestive Therapeutics Inc · EBITDA
AQST EBITDA
Latest reported-$61.39Mperiod ending
AQST TTM EBITDA ($3.02M → -$61.39M)
TTM EBITDA
High-resolution chart · PNG
AQST ebitda history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | EBITDA (USD) |
|---|---|
| -61,387,000 | |
| -51,631,000 | |
| -66,136,000 | |
| -51,377,000 | |
| -47,495,000 | |
| -36,708,000 | |
| -26,616,000 | |
| -18,226,000 | |
| -11,674,000 | |
| -17,120,000 | |
| 1,181,000 | |
| -4,762,000 | |
| -12,414,000 | |
| -20,686,000 | |
| -39,577,000 | |
| -53,951,000 | |
| -52,931,000 | |
| -46,270,000 | |
| -45,029,000 | |
| -34,768,000 | |
| -40,656,000 | |
| -34,044,000 | |
| -39,146,000 | |
| -33,892,000 | |
| -35,788,000 | |
| -54,773,000 | |
| -53,918,000 | |
| -56,090,000 | |
| -53,433,000 | |
| -69,447,000 | |
| -50,451,000 | |
| -46,272,000 | |
| -22,504,000 | |
| 8,286,000 | |
| 3,016,000 |